RBS Stock Rises on New CEO Appointment

The security is still hovering right below its year-to-date breakeven

by Lillian Currens

Published on Sep 20, 2019 at 10:18 AM

The shares of Royal Bank of Scotland Group PLC (NYSE:RBS) are higher after the financial firm appointed Alison Rose as its new CEO, marking the first time a major U.K. lender has installed a woman in its lead executive role. Rose, who has been an employee for 27 years, will be replacing Ross McEwan on Nov. 1. RBS is trading at its highest price since late July in response, up 3.8% at $5.42.

Looking more broadly, RBS has been on the rise since hitting a nearly three-year low in mid-August. Today, the equity is looking to close above its 80-day moving average -- a recent ceiling on the charts -- for the first time since April. Despite this pop, however, shares of the bank name are still hovering just below their year-to-date breakeven at $5.59. 

Analysts have been approaching RBS with caution. The security sports just one "strong buy," compared to three "hold" or "sell" ratings. 

The bank stock's quick reversal back up the charts appears to have spooked some bears, however. Short interest dropped 18.7% in the last reporting period, with the 2.24 million shares sold short now representing just 2.5 times the stock's average daily volume.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


3 Million to Lose Jobs – and Not Because of Coronavirus?
A terrifying new trend can make you a millionaire or destroy your financial future.
Dell Stock Jumps on Upbeat First Quarter
DELL announced an upbeat first-quarter report
Eli Lilly Stock Soars on FDA Approval
The FDA approved Eli Lilly's Alzheimer's disease diagnostic agent
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.